ArticleGlobal health & medicine2022

No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.

Masaaki Korenaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.